one hundred and fifteen prescriptions which were purposely written in toxic and potentially fatal dose of different medicine (mainly digitoxin) were sent to pharmacies throughout iran. all pharmacies filled up the prescription and only one pharmacist made notice of dangerous dose. the pharmacist in the drugstores in iran is forcefully employed by the owner of the pharmacy which is required by l...

funding combination is the most important issue for the companies while they know the amount of required capital. companies should be careful regarding the appliance of financial providing methods compatible with the investment strategy of company and profitability. this study seeks to examine the relationship between the capital structure and the profitability of pharmaceutical companies in ir...

as global competition intensifies, research and development (r & d) organizations need to enhance their strategic management in order to become goal-directed communities for innovation and allocate their resources consistent with their overall r & d strategy. the world pharmaceutical market has undergone fast, unprecedented, tremendous and complex changes in the last several years. the pharmace...

like many other developing countries pharmacoeconomics and outcome research and its applications in national health system is a new but promising filed in iran. although decision makers of iran national health system decided to use pharmacoeconomics in the decision making approach several hurdles including lack of reliable national data, lack of expertise and local experience are the main chall...

according to the vital role of pharmaceutical industry in health care system, pharmaceutical supply chain security, standard production and distribution of the pharmaceutical products are of great importance for pharmaceutical companies. therefore, applying technology, especially radio frequency identification (rfid), is essential to achieve these goals. moreover, due to the importance of secur...

the supply chain represents the critical link between the development of new product and the market in pharmaceutical industry. over the years, improvements made in supply chain operations have focused largely on ways to reduce cost and gain efficiencies in scale. in addition, powerful regulatory and market forces have provided new incentives for pharmaceutical firms to basically rethink the wa...

background: this article sets up the initial discussion of the evolution of biopharmaceutical innovation in china through the perspective of sectoral innovation system (sis).methods: two data sources including archival documentary data and field interviews were used in this study. archival documentary data was collected from china food and drug administration (cfda) and chinese national knowled...